T. Rowe Price Investment Management, Inc. - PROMETHEUS BIOSCIENCES INC ownership

PROMETHEUS BIOSCIENCES INC's ticker is RXDX and the CUSIP is 74349U108. A total of 224 filers reported holding PROMETHEUS BIOSCIENCES INC in Q4 2022. The put-call ratio across all filers is 1.71 and the average weighting 1.1%.

Quarter-by-quarter ownership
T. Rowe Price Investment Management, Inc. ownership history of PROMETHEUS BIOSCIENCES INC
ValueSharesWeighting
Q1 2023$93,155
-2.0%
868,006
+0.4%
0.07%
-8.2%
Q4 2022$95,100
-99.6%
864,539
+112.3%
0.07%
+284.2%
Q3 2022$24,032,000407,2510.02%
Other shareholders
PROMETHEUS BIOSCIENCES INC shareholders Q4 2022
NameSharesValueWeighting ↓
72 Investment Holdings, LLC 1,848,024$203,282,64093.46%
CHI Advisors LLC 923,800$101,618,00027.06%
Sio Capital Management, LLC 574,200$63,162,00023.36%
Cormorant Asset Management, LP 2,090,000$229,90015.38%
Boxer Capital, LLC 1,897,500$208,725,00011.00%
SEVEN GRAND MANAGERS, LLC 20,105$2,211,55010.34%
Decheng Capital Management III (Cayman), LLC 250,000$27,500,00010.29%
Ikarian Capital, LLC 288,926$31,781,8607.67%
RTW INVESTMENTS, LP 3,354,303$368,973,3307.53%
Waypoint Capital Advisors, LLC 171,181$18,829,9106.53%
View complete list of PROMETHEUS BIOSCIENCES INC shareholders